Investigation of endoglin wild-type and missense mutant protein heterodimerisation using fluorescence microscopy based IF, BiFC and FRET analyses

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Förg, Tassilo ^a   Hafner, Mathias ^a,b   Lux, Andreas ^b,c  

^a UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Q bios GmbH Biotechnology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; AMINO ACID; ENDOGLIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY SN6; MUTANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ARTICLE; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; FORSTER RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MISSENSE MUTATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN HETERODIMERIZATION; PROTEIN INTERACTION; PROTEIN POLYMERIZATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; ROUGH ENDOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; STABLE EXPRESSION; TRANSIENT EXPRESSION; WILD TYPE; ANIMAL; CELL LINE; CHO CELL LINE; CRICETULUS; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETICS; HAMSTER; PROCEDURES;

ANIMALS; ANTIGENS, CD; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; MICROSCOPY, FLUORESCENCE; MUTATION, MISSENSE; RECEPTORS, CELL SURFACE;

EID: 84905381831     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102998     Document Type: Article

References (72)

1. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, et al. (1992) Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267: 19027-19030.
2. Gougos A, Letarte M (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265: 8361-8364.
3. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, et al. (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8: 345-351.
4. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, et al. (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13: 189-195.
5. Bourdeau A, Faughnan ME, McDonald ML, Paterson AD, Wanless IR, et al. (2001) Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Am J Pathol 158: 2011-2020. (Pubitemid 32545187)
6. Goumans MJ, Mummery C (2000) Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44: 253-265.
7. Bourdeau A, Dumont DJ, Letarte M (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104: 1343-1351.
8. Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, et al. (2000) Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217: 42-53. (Pubitemid 30046798)
9. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, et al. (1999) Defective angiogenesis in mice lacking endoglin. Science 284: 1534-1537.
10. Yamashita H, Ichijo H, Grimsby S, Moren A, ten Dijke P, et al. (1994) Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta. J Biol Chem 269: 1995-2001. (Pubitemid 24035405)
11. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109: 1953-1961. (Pubitemid 46348192)
12. Scherner O, Meurer SK, Tihaa L, Gressner AM, Weiskirchen R (2007) Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling. J Biol Chem 282: 13934-13943. (Pubitemid 47100463)
13. Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, et al. (2004) Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. Embo J 23: 4018-4028. (Pubitemid 39472423)
14. Pece-Barbara N, Vera S, Kathirkamathamby K, Liebner S, Di Guglielmo GM, et al. (2005) Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway. J Biol Chem 280: 27800-27808. (Pubitemid 41076895)
15. Conley BA, Koleva R, Smith JD, Kacer D, Zhang D, et al. (2004) Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain. J Biol Chem 279: 27440-27449. (Pubitemid 38812583)
16. Sanz-Rodriguez F, Guerrero-Esteo M, Botella LM, Banville D, Vary CP, et al. (2004) Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins. J Biol Chem 279: 32858-32868. (Pubitemid 39014746)
17. Meng Q, Lux A, Holloschi A, Li J, Hughes JM, et al. (2006) Identification of Tctex2beta, a novel dynein light chain family member that interacts with different transforming growth factor-beta receptors. J Biol Chem 281: 37069-37080. (Pubitemid 46042177)
18. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, et al. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642-649. (Pubitemid 43865232)
19. Hawinkels LJ, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, et al. (2010) Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 70: 4141-4150.
20. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584. (Pubitemid 37280136)
21. Pardali E, Goumans MJ, ten Dijke P (2010) Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol 20: 556-567.
22. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, et al. (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014.
23. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, et al. (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. Embo J 21: 1743-1753. (Pubitemid 34614630)
24. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, et al. (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12: 817-828. (Pubitemid 37352776)
25. Barbara NP, Wrana JL, Letarte M (1999) Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem 274: 584-594.
26. Lee NY, Ray B, How T, Blobe GC (2008) Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC. J Biol Chem 283: 32527-32533.
27. Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, et al. (2005) Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol 204: 574-584. (Pubitemid 40934653)
28. Goumans MJ, Lebrin F, Valdimarsdottir G (2003) Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med 13: 301-307. (Pubitemid 37159396)
29. Pepper MS (1997) Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8: 21-43.
30. Gallione CJ, Klaus DJ, Yeh EY, Stenzel TT, Xue Y, et al. (1998) Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum Mutat 11: 286-294. (Pubitemid 28177870)
31. Shovlin CL, Hughes JM, Scott J, Seidman CE, Seidman JG (1997) Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61: 68-79. (Pubitemid 27323325)
32. Pece N, Vera S, Cymerman U, White RI, Jr., Wrana JL, et al. (1997) Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Invest 100: 2568-2579. (Pubitemid 27514897)
33. Paquet ME, Pece-Barbara N, Vera S, Cymerman U, Karabegovic A, et al. (2001) Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function. Hum Mol Genet 10: 1347-1357. (Pubitemid 32640663)
34. Pece-Barbara N, Cymerman U, Vera S, Marchuk DA, Letarte M (1999) Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Hum Mol Genet 8: 2171-2181. (Pubitemid 29525331)
35. Sanz-Rodriguez F, Fernandez LA, Zarrabeitia R, Perez-Molino A, Ramirez JR, et al. (2004) Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes. Clin Chem 50: 2003-2011. (Pubitemid 39425836)
36. Fernandez LA, Sanz-Rodriguez F, Zarrabeitia R, Perez-Molino A, Hebbel RP, et al. (2005) Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc Res 68: 235-248. (Pubitemid 41428420)
37. Fernandez LA, Sanz-Rodriguez F, Zarrabeitia R, Perez-Molino A, Morales C, et al. (2006) Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1. Hum Mutat 27: 295.
38. Cymerman U, Vera S, Pece-Barbara N, Bourdeau A, White RI, Jr., et al. (2000) Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatr Res 47: 24-35. (Pubitemid 30038888)
39. McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, et al. (1995) Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 4: 1983-1985.
40. Lux A, Gallione CJ, Marchuk DA (2000) Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms. Hum Mol Genet 9: 745-755. (Pubitemid 30162758)
41. Raab U, Velasco B, Lastres P, Letamendia A, Cales C, et al. (1999) Expression of normal and truncated forms of human endoglin. Biochem J 339 (Pt 3): 579-588. (Pubitemid 29243521)
42. Kerppola TK (2008) Bimolecular fluorescence complementation: visualization of molecular interactions in living cells. Methods Cell Biol 85: 431-470.
43. Pyne-Geithman GJ, Caudell DN, Cooper M, Clark JF, Shutter LA (2009) Dopamine D2-receptor-mediated increase in vascular and endothelial NOS activity ameliorates cerebral vasospasm after subarachnoid hemorrhage in vitro. Neurocrit Care 10: 225-231.
44. Maattanen P, Gehring K, Bergeron JJ, Thomas DY (2010) Protein quality control in the ER: the recognition of misfolded proteins. Semin Cell Dev Biol 21: 500-511.
45. Kerppola TK (2009) Visualization of molecular interactions using bimolecular fluorescence complementation analysis: characteristics of protein fragment complementation. Chem Soc Rev 38: 2876-2886.
46. Tao RH, Maruyama IN (2008) All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. J Cell Sci 121: 3207-3217.
47. T. Förg LP, A. Tomsche, A. Holloschi, A. Lux, M. Hafner (2010) Bimolecular fluorescence complementation (BiFC) to investigate composition and cellular localisation of homo- and heterodimeric transmembrane receptors and intracellular signalling pathways. MICROSCOPY: SCIENCE, TECHNOLOGY, APPLICATIONS AND EDUCATION ed AM-VaJD (Eds) 4: 747-755.
48. Nolan-Stevaux O, Zhong W, Culp S, Shaffer K, Hoover J, et al. (2012) Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies. PLoS One 7: e50920.
49. Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C, et al. (2000) CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. Faseb J 14: 55-64. (Pubitemid 30051523)
50. Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, et al. (1996) Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol 133: 1109-1121. (Pubitemid 26172515)
51. Letamendia A, Lastres P, Botella LM, Raab U, Langa C, et al. (1998) Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J Biol Chem 273: 33011-33019. (Pubitemid 28557696)
52. Ali BR, Ben-Rebeh I, John A, Akawi NA, Milhem RM, et al. (2011) Endoplasmic reticulum quality control is involved in the mechanism of endoglin-mediated hereditary haemorrhagic telangiectasia. PLoS One 6: e26206.
53. Pichuantes S, Vera S, Bourdeau A, Pece N, Kumar S, et al. (1997) Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments. Tissue Antigens 50: 265-276. (Pubitemid 27397334)
54. Guo B, Slevin M, Li C, Parameshwar S, Liu D, et al. (2004) CD105 inhibits transforming growth factor-beta-Smad3 signalling. Anticancer Res 24: 1337-1345. (Pubitemid 38954647)
55. Lee NY, Blobe GC (2007) The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. J Biol Chem 282: 21507-21517. (Pubitemid 47099970)
56. Pan CC, Bloodworth JC, Mythreye K, Lee NY (2012) Endoglin inhibits ERK-induced c-Myc and cyclin D1 expression to impede endothelial cell proliferation. Biochem Biophys Res Commun 424: 620-623.
57. Koleva RI, Conley BA, Romero D, Riley KS, Marto JA, et al. (2006) Endoglin structure and function: Determinants of endoglin phosphorylation by transforming growth factor-beta receptors. J Biol Chem 281: 25110-25123. (Pubitemid 44401898)
58. Ray BN, Lee NY, How T, Blobe GC (2010) ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration. Carcinogenesis 31: 435-441.
59. Anderie I, Schulz I, Schmid A (2007) Direct interaction between ER membrane-bound PTP1B and its plasma membrane-anchored targets. Cell Signal 19: 582-592. (Pubitemid 46107809)
60. Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A, Bernabeu C (2002) Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem 277: 29197-29209.
61. Lux A, Attisano L, Marchuk DA (1999) Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. J Biol Chem 274: 9984-9992.
62. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, et al. (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 97: 2626-2631. (Pubitemid 30159221)
63. Hume AN, John A, Akawi NA, Al-Awadhi AM, Al-Suwaidi SS, et al. (2013) Retention in the endoplasmic reticulum is the underlying mechanism of some hereditary haemorrhagic telangiectasia type 2 ALK1 missense mutations. Mol Cell Biochem 373: 247-257.
64. Hotamisligil GS Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900-917.
65. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, et al. (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683-690. (Pubitemid 23002027)
66. Lopez-Casillas F, Wrana JL, Massague J (1993) Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73: 1435-1444. (Pubitemid 23201155)
67. Letamendia A, Lastres P, Botella LM, Raab U, Langa C, et al. (1998) Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J Biol Chem 273: 33011-33019. (Pubitemid 28557696)
68. Marcum JA, Rosenberg RD (1985) Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells. Biochem Biophys Res Commun 126: 365-372. (Pubitemid 15173570)
69. de Agostini AI, Watkins SC, Slayter HS, Youssoufian H, Rosenberg RD (1990) Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta. J Cell Biol 111: 1293-1304.
70. Lux A, Beil C, Majety M, Barron S, Gallione CJ, et al. (2005) Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1. J Biol Chem 280: 8482-8493. (Pubitemid 40349753)
71. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, et al. (1998) Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. Embo J 17: 3091-3100. (Pubitemid 28254381)
72. Zal T, Gascoigne NR (2004) Photobleaching-corrected FRET efficiency imaging of live cells. Biophys J 86: 3923-3939. (Pubitemid 38780269)